Therapeutic considerations for postprandial dyslipidaemia

被引：6

作者：

Burnett, TR

Watts, GF

机构：

[1] Univ Western Australia, Royal Perth Hosp, Univ Dept Med, Perth, WA 6001, Australia

[2] Royal Perth Hosp, Div Lab Med, Dept Core Clin Pathol & Biochem, Perth, WA, Australia

来源：

DIABETES OBESITY & METABOLISM | 2001年 / 3卷 / 03期

关键词：

D O I：

10.1046/j.1463-1326.2001.00155.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：143 / 156

页数：14

共 151 条

[1] MECHANISM OF HYPERTRIGLYCERIDEMIA IN HUMAN APOLIPOPROTEIN-(APO)-CIII TRANSGENIC MICE - DIMINISHED VERY LOW-DENSITY-LIPOPROTEIN FRACTIONAL CATABOLIC RATE ASSOCIATED WITH INCREASED APO-CIII AND REDUCED APO-E ON THE PARTICLES [J].

AALTOSETALA, K ;

FISHER, EA ;

CHEN, XL ;

CHAJEKSHAUL, T ;

HAYEK, T ;

ZECHNER, R ;

WALSH, A ;

RAMAKRISHNAN, R ;

GINSBERG, HN ;

BRESLOW, JL .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 90 (05) :1889-1900

[2] Assessment and treatment of endothelial dysfunction in humans [J].

Anderson, TJ .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (03) :631-638

[3] Post-prandial metabolism of triglyceride-rich lipoproteins in non-insulin-dependent diabetic patients before and after bezafibrate treatment [J].

Attia, N ;

Durlach, V ;

Roche, D ;

Paul, JL ;

Soni, T ;

Zahouani, A ;

Landron, F ;

Labrousse, F ;

Leutenegger, M ;

GirardGloba, A .

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1997, 27 (01) :55-63

[4] Postprandial concentrations and distribution of apo C-III in type 2 diabetic patients. Effect of bezafibrate treatment [J].

Attia, N ;

Durlach, V ;

Cambilleau, M ;

Roche, D ;

Girard-Globa, A .

ATHEROSCLEROSIS, 2000, 149 (02) :427-433

[5] Transcriptional control of triglyceride metabolism: Fibrates and fatty acids change the expression of the LPL and apo C-III genes by activating the nuclear receptor PPAR [J].

Auwerx, J ;

Schoonjans, K ;

Fruchart, JC ;

Staels, B .

ATHEROSCLEROSIS, 1996, 124 :S29-S37

[6] Assessment of postprandial lipemia: Nutritional influences [J].

Bergeron, N ;

Havel, RJ .

CURRENT OPINION IN LIPIDOLOGY, 1997, 8 (01) :43-52

[7]

BERR F, 1985, J LIPID RES, V26, P852

[8]

Bjorkegren J, 1996, J LIPID RES, V37, P76

[9]

Bjorkegren J, 1997, J LIPID RES, V38, P301

[10] Medicinal strategies in the treatment of obesity [J].

Bray, GA ;

Tartaglia, LA .

NATURE, 2000, 404 (6778) :672-677

← 1 2 3 4 5 6 7 8 9 10 →